Hui Yang

US Patent:

8271366, Sep 18, 2012

Filed:

May 15, 2009

Appl. No.:

12/466961

Inventors:

Michael L. Coglianese - Boston MA, US
Hui Yang - Boston MA, US
David M. Curley - Boston MA, US

Assignee:

ITG Software Solutions, Inc. - Culver City CA

International Classification:

G06Q 40/00

US Classification:

705 35, 705 36 R, 705 37

Abstract:

The present invention relates to a compliance system that allows users to verify that trading rules and regulations are being followed throughout the intraday trading activity. In particular, the systems and methods of the present invention allow a user to verify compliance with trading rules locally at a trading terminal.

US Patent:

20130166431, Jun 27, 2013

Filed:

Sep 18, 2012

Appl. No.:

13/622060

Inventors:

Hui Yang - Boston MA, US
David M. Curley - Boston MA, US

Assignee:

ITG Software Solutions, Inc. - Culver City CA

International Classification:

G06Q 40/04

US Classification:

705 37

Abstract:

The present invention relates to a compliance system that allows users to verify that trading rules and regulations are being followed throughout the intraday trading activity. In particular, the systems and methods of the present invention allow a user to verify compliance with trading rules locally at a trading terminal.

US Patent:

20160186208, Jun 30, 2016

Filed:

Apr 16, 2014

Appl. No.:

14/785031

Inventors:

- Cambridge MA, US
Haoyi Wang - Cambridge MA, US
Hui Yang - Cambridge MA, US
Chikdu Shivalila - Cambridge MA, US
Wu Albert Cheng - Cambridge MA, US

International Classification:

C12N 15/85
C12N 15/90
A01K 67/027

Abstract:

The invention is directed to a method of mutating one or more target nucleic acid sequences in a stem cell or a zygote comprising introducing into the stem cell or zygote (i) ribonucleic acid (RNA) sequences that comprise a portion that is complementary to a portion of each of the target nucleic acid sequences and comprise a binding site for a CRISPR associated (Cas) protein; and a Cas nucleic acid sequence or a variant thereof that encodes a Cas protein having nuclease activity. The stem cell or zygote is maintained under conditions in which the target nucleic acid sequences are mutated in the stem cell or zygote. The invention is also directed to methods of producing a non human mammal carrying mutations and methods of modulating the expression and/or activity target nucleic acid sequences and cells or zygotes.